Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.50 (0.76%)
Bid:
65.70
Ask:
66.10
Spread: 0.40 (0.609%)
Market Cap: $41.05b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Notes Allotment Intimation

8 Sep 2021 14:17

RNS Number : 1559L
Axis Bank Limited
08 September 2021
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/274/2021-22

 

September 8, 2021

Dear Sir(s),

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Listing Regulations")

 

This is with reference to our letter no. AXIS/CO/CS/251/2021-22 dated August 30, 2021, wherein we had informed that the Bank has initiated the process of issuing of the debt instruments in the form of the Additional Tier 1 Notes in foreign currency, subject to market conditions. We also refer to our letter no. AXIS/CO/CS/262/2021-22 dated September 2, 2021, wherein we had informed that the Bank, acting through its GIFT City branch, has completed the pricing of its U.S. dollar denominated Basel III compliant Additional Tier 1 Notes (the "Notes").

 

We are pleased to inform that the Bank has raised USD 600,000,000 through the issue and allotment of USD denominated, unsecured, 4.10% Basel III compliant, Additional Tier 1 Notes (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act.

 

The Notes will be listed on Singapore Exchange Limited, International Securities Market, India International Exchange (IFSC) Limited and the NSE IFSC Limited (NSE International Exchange).

 

This is for information of all concerned, in compliance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

 

Thanking you,

 

Yours sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary

 

DISCLAIMER

 

The Offering Circular ("OC") for the GMTN programme has not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Registrar of Companies ("RoC"), the Securities and Exchange Board of India ("SEBI") or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules framed thereunder or any other applicable Indian laws.

 

The OC has not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the SEBI, the RoC, the Reserve Bank of India, or any stock exchange in India. This OC and the Additional Tier 1 Notes ("Notes") are not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

 

This information relates to an offering of the Notes to be offered and sold (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act. This information is not an offer of securities for sale in the United States. The Notes referred to herein have not been and will not be registered under the U.S. Securities Act or the laws of any state of the United States or elsewhere and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws of the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States or in any other jurisdiction. Nothing in this communication shall constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer or sale would be unlawful. No money, securities or other consideration is being solicited by this announcement or the information contained herein and, if sent in response to this announcement or the information contained herein, will not be accepted.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNPEFLFEFA
Date   Source Headline
20th Nov 20247:00 amRNSRating Action by CRISIL
24th Oct 20242:21 pmRNSRe-Appointment of Amitabh Chaudhry as the MD CEO
24th Oct 20241:23 pmRNSCHANGES IN SENIOR MANAGEMENT OF AXIS BANK LIMITED
17th Oct 20244:16 pmRNScredit rating by ICRA
17th Oct 202412:35 pmRNSResults Q2FY25
7th Oct 20241:41 pmRNSREGULATION 29 AND 50 OF THE SEBI LODR 2015
1st Oct 20245:38 pmRNSRating action by India Ratings and Research
1st Oct 20247:00 amRNSDisclosure under Reg 30 of SEBI LODR 2015
27th Sep 20246:19 pmRNSRating action by CARE Ratings
20th Sep 20247:00 amRNSClarification w.r.t. Interim Order issued to ACL
12th Sep 202411:04 amRNSCredit Rating - S&P Global Ratings
11th Sep 20247:00 amRNSDisclosure under Reg 30 SEBI LODR Regulations 2015
5th Sep 20249:20 amRNSAllotment of NCDs Series 8
2nd Sep 20247:00 amRNSCredit Rating - Moody's
30th Aug 20241:44 pmRNSIssuance of NCDs (Series 8)
26th Jul 20244:43 pmRNSAGM Proceedings
24th Jul 202412:18 pmRNSInvestor Presentation and Press Release Q1FY25
24th Jul 202412:12 pmRNSQ1FY25 Results
11th Jul 20249:30 amRNSGrant of Stock Options
5th Jul 20242:11 pmRNSBoard Meeting Intimation
28th Jun 20243:34 pmRNSBRSR
28th Jun 20243:33 pmRNSNotice of the 30th AGM & Integrated Annual Report
5th Jun 20249:06 amRNSDisclosure under Regulation 30 of SEBI LODR
5th Jun 20247:00 amRNSCredit Rating - S&P Global Ratings
10th May 20245:00 pmRNSCredit Rating - Fitch Ratings
10th May 20244:35 pmRNSResults of Postal Ballot
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:53 amRNSRevision in Vesting Period - ESOS
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
15th Dec 20238:36 amRNSCessation
1st Dec 20231:52 pmRNSPostal Ballot Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.